Oscar Health (OSCR) Receivables (2020 - 2026)

Oscar Health has reported Receivables for 7 years, with the latest figure at $587.0 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables rose 20.1% year-over-year to $587.0 million; the trailing twelve-month figure through Mar 2026 stood at $587.0 million (up 20.1% YoY), and the FY2025 full-year result was $362.7 million, up 14.81% from the prior year.
• Receivables for Q1 2026 stood at $587.0 million, up from $362.7 million in the prior quarter.
• The five-year high for Receivables was $587.0 million in Q1 2026, with the low at $157.3 million in Q1 2022.
• Historically, Receivables has averaged $309.3 million across 5 years, with a median of $300.6 million in 2024.
• Annual changes were most pronounced in 2022 — Receivables surged 107.38% — and 2023, when it fell 7.02%.
• Oscar Health's Receivables stood at $216.5 million in 2022, then slipped by 7.02% to $201.3 million in 2023, then soared by 56.95% to $315.9 million in 2024, then rose by 14.81% to $362.7 million in 2025, then soared by 61.86% to $587.0 million in 2026.
• The last three Receivables figures came in at $587.0 million (Q1 2026), $362.7 million (Q4 2025), and $445.5 million (Q3 2025), per Business Quant data.